Masonic Cancer Center

A comprehensive cancer center designated by the National Cancer Institute

Funding Opportunities

Extramural Grant Review Opportunity Available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Aaron Schilz, schil226@umn.edu, 624-0650.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.

News and Notices  

New Biographical Sketch Format Required for NIH and AHRQ Grant Applications Submitted for Due Dates on or After January 25, 2015 (NOT-OD-15-024)
National Institutes of Health
NIH and AHRQ will require use of a new biosketch format in applications for research grants submitted for due dates on or after January 25, 2015. Between now and that time, applicants will have the choice of using the old or new biosketch format.

New NIH Genomic Data Sharing Policy
(NOT-OD-14-124)
Office of the Director, NIH

Piloting Modified NIH Biosketches

(NOT-OD-14-091)
National Institutes of Health
The new Biosketch format being piloted will extend the page limit from four to five pages and it will allow researchers to describe up to five of their most significant contributions to science along with the historical background that framed their research.

NIH Announces Significant Change in Policy for Application Submissions
(NOT-OD-14-074)
National Institutes of Health

NIH Issues 2014 Funding Levels
Non-competing continuation awards that have already been made in FY 2014 were generally funded at levels below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). Such reductions may be fully or partially restored, depending on the Institute or Center. Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2014 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level.

NIH Publication Compliance and RPPR Progress Reports (PDF)
Click on the title of this notice for a PDF containing a list of several helpful resources for navigating, monitoring, and managing publication compliance. For more information or questions, please contact Aaron Schilz, Research Grant Coordinator, schil226@umn.edu.

Funding Opportunities 

ASSIST To Become an Option for Submission of Applications for Most Competing Grant Programs in 2015
(NOT-OD-15-044)

Child Health Collaborative Award
CTSI and Department of Pediatrics and. Children’s Hospitals and Clinics of Minnesota
Deadline: LOI – 1/30/15; Full application by invitation – May 1, 2015
Funding: Up to $200,000 for 2 years

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
(PAR-15-075)
National Cancer Institute
Application Receipt Date(s): The first due date for all types of applications allowed for this FOA is March 6, 2015. Thereafter Standard dates apply, by 5:00 PM local time of applicant organization.
Funding: Standard R01 limits apply

Biomedical Data Science Training Coordination Center (U24)
(RFA-ES-15-004)
Application Receipt Date(s): March 17, 2015
Funding: $1.4M/yr for 3 years

Empirical Research on Ethical Issues Related to Central IRBs and Consent for Research Using Clinical Records and Data (R01)
(RFA-OD-15-002)
Application Receipt Date(s): February 19, 2015
Funding: Standard R01 limits apply

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)
(PAR-15-064)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: $100,000/yr towards salary; $30,000/yr for other expenses

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)
(PAR-15-060)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: $100,000/yr towards salary; $30,000/yr for other expenses

NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)
(PAR-15-062)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: $100,000/yr towards salary; $30,000/yr for other expenses

2015 Breast Cancer Research Program
Avon Foundation
Letter of Intent Deadline: January 15, 2015
Full Application Deadline: July 30, 2015
Funding: $300,000 over 2 years

New RFA to Support Research Projects with Commercial Potential
The new Translational Product Development Fund program is now accepting applications from investigators at the University and the Mayo Clinic, and will award funded projects up to either $50,000 or $200,000. The program supports projects that intend to develop a novel therapeutic compound (i.e., drug, small molecule, or biologic), device, diagnostic, or IT product, and have the potential to be commercialized. The Clinical and Translational Science Institute (CTSI) and the Mayo Clinic Center for Clinical and Translational Science (CCaTS) established the program in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics. Mandatory letters of intent (LOIs) are due by 5pm on December 19, 2014 (Cycle 1) and May 1, 2015 (Cycle 2).

RFA to Support Research Conducted at the 2015 State Fair
The Clinical and Translational Science Institute's (CTSI) Driven to Discover Community Health Research Grants Program is now accepting applications. The program enables funded projects to use the Driven to Discover research building at the State Fair to enroll and collect data from fairgoers. Letters of interest (optional) are due Dec. 5, while full proposals are due Jan. 9, 2015.

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) 
(PAR-15-053)
National Cancer Institute
Application Receipt/Submission Date(s): June 22, 2015; November 30, 2015; see announcement for additional dates.
Funding: Standard R21 limits apply.

Driven to Discover State Fair Pilot Grants
Masonic Cancer Center, School of Public Health, Medical School, CFANS
Deadline: January 9, 2015
Funding: 1-3 grants worth a combined $15,000

Damon Runyon Clinical Investigator Award
Damon Runyon Cancer Research Foundation
Internal Review Preapplication Deadline: January 9, 2015
Full Application Deadline (if invited): February 17, 2015
Funding: $450,000 over 3 years

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01)
(PAR-15-021)
National Cancer Institute
Application Receipt Date(s): February 26, 2015; November 25, 2015; see announcement for additional dates
Funding: $500,000 per year for 5 years

National Cancer Institute Program Project Applications (P01)
(PAR-15-023)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Varies.

Environmental Influences during Windows of Susceptibility in Breast Cancer Risk (U01)
(RFA-ES-14-012)
National Cancer Institute
Application Receipt Date(s): January 28, 2015
Funding: $600,000/yr for 5 years

Collaborative Activities to Promote Metabolomics Research (Admin Supp)
(PA-15-030)
NIH Roadmap Initiatives
National Cancer Institute
Application Receipt Date(s): February 13, 2015
Funding: $100,000 for 1 year

Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research
AACR
Application Deadline: Tuesday, Jan. 20, 2015
Funding: $138,000 over 2 yrs

RFAs: Research career development opportunities for U of M assistant professors 
The Clinical and Translational Science Institute (CTSI) is now accepting applications for three programs that help junior investigators build independent research careers. Programs provide a comprehensive career development infrastructure that supports awardees via funding, mentorship, weekly seminars, individualized development plans, and ongoing support. Applications are due Dec. 18.

RFA: Research opportunity for health sciences students
Doctoral or professional health sciences students (PhD, DDS, DNP, MD, PharmD) with an interest in research are encourage to apply for the Summer Advanced Research Program. The program from the University’s Clinical and Translational Science Institute (CTSI) and the Center for Health Equity (CHE) provides a weekly stipend, a structured core curriculum, mentored research projects, weekly research seminars, and a final presentation of research. Applications are due by Feb. 6, 2015.

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50)
(PAR-14-353)
National Cancer Institute
Application Receipt Date(s): January 27, 2015; May 19, 2015; September 22, 2015; January 27, 2016; May 19, 2016; September 22, 2016
Funding: $2,300,000 total costs/year

Advancing Interventions to Improve Medication Adherence
PA-14-334 – R01
PA-14-335 – R21
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard R01 & R21 limit

Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)
(PAR-14-242)
National Cancer Institute
Application Receipt Date(s):  March 3, 2015; See announcement for additional dates.
Funding: Standard R01 limits apply.

Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)
(PAR-14-260)
National Cancer Institute
Application Receipt Date(s): May 12, 2015, May 12, 2016, See announcement for additional dates.
Funding: Standard R01 limits apply.

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33)
(PAR-14-230)
National Cancer Institute
Application Receipt Date(s): April 15, 2015, August 17, 2015, December 15, 2015. See announcement for additional deadlines.
Funding: The R21 phase may not exceed two years or $275,000 in direct costs, with no more than $150,000 in direct costs in any single year of the R21 phase.  The R33 phase may not exceed three years or $450,000 in direct costs, with no more than $225,000 in direct costs in any single year of the R33 phase.

Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33)
(PAR-14-230)
National Cancer Institute
Application Receipt Date(s):  April 15, 2015, August 17, 2015, December 15, 2015. See announcement for additional deadlines.
Funding: The R21 phase may not exceed two years or $275,000 in direct costs, with no more than $150,000 in direct costs in any single year of the R21 phase.  The R33 phase may not exceed three years or $450,000 in direct costs, with no more than $225,000 in direct costs in any single year of the R33 phase.

Predoctoral Training in Biomedical Big Data Science (T32)
(RFA-HG-14-004)
National Cancer Institute
Application Receipt Date(s): July 27, 2015, by 5:00 PM local time of applicant organization.
Funding: Average size budget of $350,000/yr total costs for 5 years

Genomic Resource Grants for Community Resource Projects (U41)
(PAR-14-191)
National Cancer Institute
Application Receipt Date(s):  January 25, 2015; May 25, 2015; September 25, 2015; January 25, 2016; May 25, 2016; September 25, 2016; January 25, 2017 
Funding: 5 years of funding.  Application budgets are not limited, but should reflect the needs of the proposed project.

THE U OF M INFORMATICS INSTITUTE (UMII) has announced two major funding initiatives at the interface of informatics and its applications: the UMII Transdisciplinary Research Fellowship will position recently promoted associate professors to provide leadership in transdisciplinary collaborative projects, and the UMII Faculty in Industry Fellowship will enable faculty to build strong partnerships with Minnesota businesses or agencies to develop long-term projects that address critical societal challenges. For more information, see UMII .

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)
(PA-14-114)
National Cancer Institute
Funding: Standard R01 limits apply.
Application Receipt Date(s): Multiple dates, see announcement.

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)
(PAR-14-013)
National Cancer Institute
Funding: Standard R21 limits apply
Deadline: See announcement for dates.

Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)
(PAR-14-116)
National Cancer Institute
Funding: $500,000/yr for 5 years
Application Receipt Date(s): Multiple dates, see announcement 

Modeling Social Behavior (R01)

(PAR-13-374)
National Cancer Institute
Deadline: Multiple dates, see announcement.
Funding: Standard R01 limits apply.

Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
(PAR-13-375)
National Cancer Institute
Deadline:  March 19, 2015; March 22, 2016
Funding: Standard R01 limits apply.

TTR Core Usage Funding Program
Sponsor: Office of Discovery and Translation - CTSI
Application Deadline (ongoing): 5 p.m. on the 10th day of any month
Funding: up to $10,000 to use a TTR-designated Core Resource for up to one year
The Core Usage Funding Program is designed to support clinical or translational projects. Basic research projects are ineligible. The supported studies may be either pilot projects, intended to generate preliminary data for larger studies, or projects nearing the final stages of completion but now require additional data the Core Resources can generate. It is expected that a Core Usage grant will be used to generate data to support an external grant submission or patent application.

Pancreatic Cancer Action Network Research Grants Program
Sponsor: Pancreatic Cancer Action Network and American Association for Cancer Research
Deadlines: Multiple; see announcement
Funding: See announcement
Funding is available for postdoctoral/clinical research fellows as well as for junior and senior independent researchers. The proposed research must be directly relevant to pancreatic cancer. More information about the grants program, including eligibility criteria and application due dates and procedures, is available at http://www.pancan.org/2014grants..

Research to Characterize and Reduce Stigma to Improve Health
R01 (PA-13-248)
R03 (PA-13-247)
R21 (PA-13-246)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.  Standard cycle dates.
Funding: Standard limits apply

Tobacco Control Regulatory Research
R01 (RFA-OD-13-011)
R03 (RFA-OD-13-012)
R21 (RFA-OD-13-010)
U.S. Food and Drug Administration, Center for Tobacco Products
National Cancer Institute
Application Receipt Date:January 16, 2015
Funding: R01 - $499,999 direct costs per year; standard limits for R03 and R21 applications.

Prostate Cancer Research Program (PCRP)
Sponsor: Department of Defense
Deadlines: Various; see announcements
Funding: See announcements

Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness
R01 (PA-13-165)
R15 (PA-13-166)
R21 (PA-13-167)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: Standard limits apply. See announcements for additional information.

Bioengineering Research Grants (BRG) (R01)
(PAR-13-137)
National Cancer Institute
Application Deadline: Multiple receipt dates, see announcement. 
Funding: Standard R01 limits apply

Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)
(PAR-13-169)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
Funding: standard R01 limits apply       

Research Funding Resources
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on December 30, 2014